NGeneBio Co., Ltd. Logo

NGeneBio Co., Ltd.

Provides NGS-based diagnostics, software, and liquid biopsy for precision oncology and healthcare.

354200 | KO

Overview

Corporate Details

ISIN(s):
KR7354200008
LEI:
Country:
South Korea
Address:
서울특별시 구로구 디지털로 288 303호. 304호. 305호. 306호. 307호. 제지1층 제비 127호, 제지1층 제비 1, 구로구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NGeneBio Co., Ltd. is a biotechnology company specializing in molecular diagnostics (MDx) and companion diagnostics (CDx) based on Next-Generation Sequencing (NGS) technology. The company develops and provides precision diagnostic solutions, including NGS-based panels for oncology (e.g., breast and ovarian cancer), bioinformatics analysis software, and liquid biopsy products. NGeneBio also offers personalized genetic-based healthcare services. As a leading supplier to hospitals in its domestic market, the company is focused on expanding its presence in the global precision medicine field.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-09-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.2 KB
2025-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 125.6 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 2.2 MB
2025-08-01 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 124.6 KB
2025-08-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-01 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-07-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 146.8 KB
2025-06-30 00:00
Board/Management Information
대표이사변경
Korean 10.7 KB
2025-06-27 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.6 KB
2025-06-27 00:00
Share Issue/Capital Change
[기재정정]주요사항보고서(유상증자결정)
Korean 60.8 KB
2025-06-27 00:00
Major Shareholding Notification
최대주주인명목회사·조합등의최대주주변경
Korean 15.0 KB
2025-06-26 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 21.7 KB
2025-06-26 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 15.0 KB
2025-06-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 102.7 KB

Automate Your Workflow. Get a real-time feed of all NGeneBio Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NGeneBio Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NGeneBio Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Ectin Research AB Logo
Clinical-stage biotech developing novel cancer treatments, focusing on metastatic bladder cancer.
Sweden
ECTIN B
Edesa Biotech, Inc. Logo
Develops treatments for inflammatory and immune diseases like Acute Respiratory Distress Syndrome.
United States of America
EDSA
Edgewise Therapeutics, Inc. Logo
Developing novel therapeutics for rare and serious muscle disorders.
United States of America
EWTX
Editas Medicine, Inc. Logo
Developing CRISPR-based genomic medicines to treat serious and rare genetic diseases.
United States of America
EDIT
Eevia Health Plc Logo
Manufactures validated polyphenol extracts from Arctic plants for the supplement & food industries.
Finland
EEVIA
Egetis Therapeutics Logo
Develops and commercializes drugs for serious rare diseases with unmet medical needs.
Sweden
EGTX
EIKEN CHEMICAL CO.,LTD. Logo
Manufacturer of clinical diagnostics, specializing in FIT systems for cancer and microbiological tests.
Japan
4549
Eisai Co., Ltd. Logo
A global, research-based pharmaceutical firm that develops and markets prescription and OTC drugs.
Japan
4523
Elanco Animal Health Inc Logo
Develops medicines, vaccines, and services to treat and prevent disease in pets and farm animals.
United States of America
ELAN
Eledon Pharmaceuticals, Inc. Logo
Develops immunomodulatory therapies to prevent organ rejection in transplant patients.
United States of America
ELDN

Talk to a Data Expert

Have a question? We'll get back to you promptly.